Coding and Billing

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Coding and Billing

  Bundled code Exceptions Uterus with fallopian tubes and ovaries 88309 (uterine tumor) or 88307 (nonneoplastic) Ovary contains possible tumor Mastectomy with regional lymph nodes 88309 Lymph node is designated…

read more

The Income Statement

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on The Income Statement

Fig. 7.1 Mountain Pathology Income Statement I Note the overall structure of the income statement: Revenue−Expense = Net income. Each month the accountant updates the income statement and the two most senior…

read more

Bringing It All Together

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Bringing It All Together

© Springer International Publishing Switzerland 2016Lewis A. Hassell, Michael L. Talbert and Jane Pine Wood (eds.)Pathology Practice Management10.1007/978-3-319-22954-6_24 24. Bringing It All Together Michael L. Talbert1   (1) Department of Pathology, University of Oklahoma Health Sciences Center, 940…

read more

The High-Performing Practice into the Future

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on The High-Performing Practice into the Future

© Springer International Publishing Switzerland 2016Lewis A. Hassell, Michael L. Talbert and Jane Pine Wood (eds.)Pathology Practice Management10.1007/978-3-319-22954-6_23 23. The High-Performing Practice into the Future Lewis Hassell1   and Michael L. Talbert1   (1) Department of Pathology, University of Oklahoma…

read more

Opportunities and Entrepreneurism

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Opportunities and Entrepreneurism

© Springer International Publishing Switzerland 2016Lewis A. Hassell, Michael L. Talbert and Jane Pine Wood (eds.)Pathology Practice Management10.1007/978-3-319-22954-6_21 21. Opportunities and Entrepreneurism Lewis A. Hassell1   and Michael L. Talbert1   (1) Department of Pathology, University of Oklahoma Health Sciences…

read more

Revenue Cycle Management

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Revenue Cycle Management

Key business consideration In-house operation Contracted service Significant front-end capital investment required Yes No Substantial lead time before start-up required Frequent Infrequent Upgrades and innovations readily implemented Sometimes Usually Close…

read more

Technologic and Regulatory Risks

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Technologic and Regulatory Risks

Regulatory entity Primary domain Examples of lab regulations Centers for Medicare/Medicaid Services (CMS) What gets paid for CLIA regulations regarding lab medical directors and accreditation requirements; payment or coding policies…

read more

Trends Towards Outcomes, Accountable Care, and Value-Based Purchasing

Oct 29, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Trends Towards Outcomes, Accountable Care, and Value-Based Purchasing

© Springer International Publishing Switzerland 2016Lewis A. Hassell, Michael L. Talbert and Jane Pine Wood (eds.)Pathology Practice Management10.1007/978-3-319-22954-6_2 2. Trends Towards Outcomes, Accountable Care, and Value-Based Purchasing Dale W. Bratzler1   (1) Health Administration and Policy, College of…

read more
Get Clinical Tree app for offline access